4.8 Article

Prohibitin is required for transcriptional repression by the WT1-BASP1 complex

期刊

ONCOGENE
卷 33, 期 43, 页码 5100-5108

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2013.447

关键词

WT1; BASP1; prohibitin; transcription

资金

  1. National Institute of General Medical Sciences [1R01GM098609]
  2. Cancer Research UK [C1356/A6630]
  3. National Science Foundation [DBI 0923133]

向作者/读者索取更多资源

The Wilms' tumor-1 protein (WT1) is a transcriptional regulator that can either activate or repress genes controlling cell growth, apoptosis and differentiation. The transcriptional corepressor BASP1 interacts with WT1 and mediates WT1's transcriptional repression activity. BASP1 is contained within large complexes, suggesting that it works in concert with other factors. Here we report that the transcriptional repressor prohibitin is part of the WT1-BASP1 transcriptional repression complex. Prohibitin interacts with BASP1, colocalizes with BASP1 in the nucleus, and is recruited to the promoter region of WT1 target genes to elicit BASP1-dependent transcriptional repression. We demonstrate that prohibitin and BASP1 cooperate to recruit the chromatin remodeling factor BRG1 to WT1-responsive promoters and that this results in the dissociation of CBP from the promoter region of WT1 target genes. As seen with BASP1, prohibitin can associate with phospholipids. We demonstrate that the recruitment of PIP2 and HDAC1 to WT1 target genes is also dependent on the concerted activity of BASP1 and prohibitin. Our findings provide new insights into the function of prohibitin in transcriptional regulation and uncover a BASP1-prohibitin complex that plays an essential role in the PIP2-dependent recruitment of chromatin remodeling activities to the promoter.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Correction Oncology

Overview of the relevance of PI3K pathway in HR-positive breast cancer (vol 30, pg 3, 2019)

N. Vasan, E. Toska, M. Scaltriti

ANNALS OF ONCOLOGY (2020)

Article Genetics & Heredity

ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer

Guotai Xu, Sagar Chhangawala, Emiliano Cocco, Pedram Razavi, Yanyan Cai, Jordan E. Otto, Lorenzo Ferrando, Pier Selenica, Erik Ladewig, Carmen Chan, Arnaud Da Cruz Paula, Matthew Witkin, Yuanming Cheng, Jane Park, Cristian Serna-Tamayo, HuiYong Zhao, Fan Wu, Mirna Sallaku, Xuan Qu, Alison Zhao, Clayton K. Collings, Andrew R. D'Avino, Komal Jhaveri, Richard Koche, Ross L. Levine, Jorge S. Reis-Filho, Cigall Kadoch, Maurizio Scaltriti, Christina S. Leslie, Jose Baselga, Eneda Toska

NATURE GENETICS (2020)

Article Endocrinology & Metabolism

Differential Effects of Diet and Weight on Taste Responses in Diet-Induced Obese Mice

Zachary C. Ahart, Laura E. Martin, Bailey R. Kemp, Debarghya Dutta Banik, Stefan G. E. Roberts, Ann-Marie Torregrossa, Kathryn F. Medler

OBESITY (2020)

Article Oncology

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

Patrizia Mondello, Saber Tadros, Matt Teater, Lorena Fontan, Aaron Y. Chang, Neeraj Jain, Haopeng Yang, Shailbala Singh, Hsia-Yuan Ying, Chi-Shuen Chu, Man Chun John Ma, Eneda Toska, Stefan Alig, Matthew Durant, Elisa de Stanchina, Sreejoyee Ghosh, Anja Mottok, Loretta Nastoupil, Sattva S. Neelapu, Oliver Weigert, Giorgio Inghirami, Jose Baselga, Anas Younes, Cassian Yee, Ahmet Dogan, David A. Scheinberg, Robert G. Roeder, Ari M. Melnick, Michael R. Green

CANCER DISCOVERY (2020)

Article Genetics & Heredity

A subset of broadly responsive Type III taste cells contribute to the detection of bitter, sweet and umami stimuli

Debarghya Dutta Banik, Eric D. Benfey, Laura E. Martin, Kristen E. Kay, Gregory C. Loney, Amy R. Nelson, Zachary C. Ahart, Barrett T. Kemp, Bailey R. Kemp, Ann-Marie Torregrossa, Kathryn F. Medler

PLOS GENETICS (2020)

Article Oncology

FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer

Amaia Arruabarrena-Aristorena, Jesper L. V. Maag, Srushti Kittane, Yanyan Cai, Wouter R. Karthaus, Erik Ladewig, Jane Park, Srinivasaraghavan Kannan, Lorenzo Ferrando, Emiliano Cocco, Sik Y. Ho, Daisylyn S. Tan, Mirna Sallaku, Fan Wu, Barbara Acevedo, Pier Selenica, Dara S. Ross, Matthew Witkin, Charles L. Sawyers, Jorge S. Reis-Filho, Chandra S. Verma, Ralf Jauch, Richard Koche, Jose Baselga, Pedram Razavi, Eneda Toska, Maurizio Scaltriti

CANCER CELL (2020)

Article Biochemistry & Molecular Biology

WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1

Tareg Belali, Chigeru Wodi, Bethany Clark, Man-Kim Cheung, Tim J. Craig, Gabrielle Wheway, Nicole Wagner, Kay-Dietrich Wagner, Stefan Roberts, Sean Porazinski, Michael Ladomery

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2020)

Article Multidisciplinary Sciences

Cholesterol is required for transcriptional repression by BASP1

Amy E. Loats, Samantha Carrera, Anna F. Fleming, Abigail R. E. Roberts, Alice Sherrard, Eneda Toska, Alexander J. Moorhouse, Kathryn F. Medler, Stefan G. E. Roberts

Summary: The study reveals that the lipidated protein BASP1 recruits cholesterol to the promoter region of target genes in the cell nucleus through a conserved interaction motif, and that BASP1's interaction with cholesterol is required for chromatin remodeling and the direction of transcription programs controlling cell differentiation.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Multidisciplinary Sciences

UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth

Andrew L. Wolfe, Qingwen Zhou, Eneda Toska, Jacqueline Galeas, Angel A. Ku, Richard P. Koche, Sourav Bandyopadhyay, Maurizio Scaltriti, Carlito B. Lebrilla, Frank McCormick, Sung Eun Kim

Summary: The enzyme UGP2, which synthesizes UDP-glucose, plays a crucial role in maintaining pancreatic ductal adenocarcinoma (PDAC) growth. Its transcription is directly regulated by the YAP-TEAD complex, and loss of UGP2 leads to decreased glycogen levels and defects in glycosylation of important targets for PDAC survival.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Letter Hematology

Crosstalk between β-catenin and WT1 signaling activity in acute myeloid leukemia

Megan Wagstaff, Olga Tsaponina, Gilian Caalim, Hayley Greenfield, Leanne Milton-Harris, Erika J. Mancini, Allison Blair, Kate J. Heesom, Alex Tonks, Richard L. Darley, Stefan G. Roberts, Rhys G. Morgan

HAEMATOLOGICA (2023)

Article Multidisciplinary Sciences

The BASP1 transcriptional corepressor modifies chromatin through lipid-dependent and lipid-independent mechanisms

Alexander J. Moorhouse, Amy E. Loats, Kathryn F. Medler, Stefan G. E. Roberts

Summary: The transcriptional corepressor BASP1 requires N-terminal myristoylation for its activity and functions through interactions with nuclear lipids. Removal of active histone modifications H3K9ac and H3K4me3 by BASP1 requires N-terminal myristoylation, while placement of the repressive histone modification H3K27me3 does not require lipidation. BASP1 regulates activity of multiple transcription factors and induces extensive changes in chromatin accessibility, with about 50% of BASP1 target genes showing lipidation-dependent chromatin compaction and transcriptional repression.

ISCIENCE (2022)

Editorial Material Oncology

A Unique FOXA1-Associated Chromatin State Dictates Therapeutic Resistance in Lobular Breast Cancer

Ryan Blawski, Eneda Toska

Summary: In this study, the authors investigated the mechanisms of differential therapy response in invasive lobular carcinomas (ILC) compared to invasive ductal carcinomas (IDC). They found an alternative chromatin accessibility state in ILC driven by the pioneer factor FOXA1, which promotes the transcription of genes associated with tumor progression and tamoxifen resistance. Targeting the FOXA1 enhancer region blocks this transcriptional program and inhibits ILC proliferation.

CANCER RESEARCH (2022)

Article Oncology

BASP1 down-regulates RANKL-induced osteoclastogenesis

Anuj Anuj, Nina Reuven, Stefan G. E. Roberts, Ari Elson

Summary: The cytokine RANKL is involved in the differentiation of monocytes/macrophages into bone-resorbing osteoclasts, and it down-regulates the expression of BASP1 which is a negative regulator of osteoclastogenesis. Knocking down or eliminating BASP1 enhances RANKL-induced osteoclastogenesis, promoting cell-cell fusion and increasing mineral degrading abilities of osteoclasts.

EXPERIMENTAL CELL RESEARCH (2023)

Review Physiology

Bitter, sweet, and umami signaling in taste cells: it's not as simple as we thought

Debarghya Dutta Banik, Kathryn F. Medler

Summary: The taste system uses distinct signaling pathways to detect chemicals in potential food items, with bitter, sweet and umami stimuli activating GPCR pathways while salt and sour are detected by ionotropic receptors. Recent studies suggest that the signaling processes in taste cells are more complex than previously appreciated.

CURRENT OPINION IN PHYSIOLOGY (2021)

暂无数据